Navigation Links
Consumer Advocates Support Patent Office on Stem Cell Patent Rejection
Date:11/5/2007

SANTA MONICA, Calif., Nov. 5 /PRNewswire-USNewswire/ -- Amended stem cell patent claims submitted by the Wisconsin Alumni Research Foundation don't overcome the U.S. Patent Office Examiner's rejections and the claims remain unpatentable, two consumer groups said today.

In formal comments filed Friday the Foundation for Taxpayer and Consumer Rights (FTCR) and the Public Patent Foundation (PUBPAT) asked that the rejections first issued on March 30 by the U.S. PTO be made final.

"Stem cell science would be best served if WARF simply withdrew their overreaching claims," said John M. Simpson, FTCR's stem cell project director.

In July 2006 the FTCR and PUBPAT challenged three patents held by WARF because they are hindering stem cell research. Stem Cell Scientist Dr. Jeanne Loring supported the challenge, which led to the rejection of all claims of all three patents in March.

In June WARF offered counter arguments and then in October filed what it described as "technical amendments" to the patent claims.

"Upon review, however, none of those amendments are sufficient to overcome the Examiner's rejections," wrote Daniel B. Ravicher, PUBPAT's executive director. "As such, the claims remain unpatentable."

Read the filing here: http://www.consumerwatchdog.org/resources/913SuppComments.pdf

Four internationally known stem cell scientists, Loring of the Burnham Institute for Medical Research, soon to join the Scripps Research Institute; Dr. Douglas Melton of Harvard University; Dr. Alan Trounson of Monash University in Australia, soon to take over as president of the California Institute for Regenerative Medicine; and Dr. Chad Cowan of Harvard University filed declarations supporting the consumer groups and the PTO's earlier finding that the work done by Dr. James Thomson does not deserve a patent.

WARF holds three stem cell patents, numbers '780, '806 and '913, based on work done by Thomson. The rules applicable to the '913 case under a so-called "inter partes" re-examination allow the challengers to comment on WARF's responses in that proceeding.

The two earlier patents are undergoing "ex parte" re-examination and those rules do not allow formal comment from FTCR and PUBPAT. Nonetheless, the points made by FTCR and PUBPAT in the '913 case are relevant to the other two.

Since the groups filed their challenge, WARF has substantially eased licensing requirements for stem cell researchers

The Foundation for Taxpayer and Consumer Rights is California's leading non-profit and non-partisan consumer watchdog group. For more information visit us on the web at: http://www.ConsumerWatchdog.org and http://www.oilwatchdog.org.

The Public Patent Foundation is a not-for-profit legal services organization that represents the public's interests against the harms caused by the patent system, particularly the harms caused by wrongly issued patents and unsound patent policy. For more information, visit us on the web at http://www.pubpat.org.


'/>"/>
SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
2. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
3. EntreMed Raises $20 Million to Support Clinical Development Program
4. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
5. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
6. Isis Reports Preclinical Data Supporting Liver Safety of ISIS 301012
7. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
8. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
9. Data Support use of SuperGens CLIMB Technology in Lead Development and Optimization
10. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
11. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate ... primary prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Mohebi Hair Restoration, has recently contributed a medical article to the newly revamped ... cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular ...
Breaking Medicine News(10 mins):